RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$385 | -$391 | -$367 | -$546 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $86 | $86 | $86 | $252 |
| Change in WC | $51 | $58 | -$7 | $17 |
| Other Non-Cash | $58 | $59 | $59 | $59 |
| Operating Cash Flow | -$189 | -$188 | -$228 | -$219 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $9 | $0 | $0 |
| Financing Cash Flow | $0 | $5 | -$1 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$189 | -$188 | -$228 | -$219 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $291 | $478 | $707 | $925 |
| End Cash | $102 | $291 | $478 | $707 |
| Free Cash Flow | -$189 | -$188 | -$228 | -$219 |